The role of Sox9 in the onset, progression and treatment of Calcific Aortic Valve Disease

Joy Lincoln, PhD

Nationwide Children's Hospital/Ohio State University

Dr. Lincoln completed her PhD in molecular biology at The University of Durham in the UK and her Post Doctoral training with Dr. Katherine Yutzey at Cincinnati Children’s Hospital Medical Center. She joined faculty at the University of Miami, Florida in 2006 and relocated to Nationwide Children’s Hospital in 2011 where she holds a Principal Investigator position in the Center of Cardiovascular Research and Tenured Associate Professor at The Ohio State University. Her lab is focused on defining the mechanisms that underlie congenital heart valve malformations and understanding the etiology of valve disease acquired after birth. Studies form her lab have made significant contributions to the field and identified critical signaling pathways that regulate cell fate determination of valve cell populations in development and disease. Dr. Lincoln served at Director of the Post Doctoral Training Office at The University of Miami and is the current Associate Director of Faculty Development at Nationwide Children’s Hospital.

Session

IV5 » Invited Speaker (17:00 - Thursday, 8th September, Max Bell Auditorium)